Treatment Planning Software Support Radiotherapy Systems
|
By MedImaging International staff writers Posted on 01 Jul 2021 |

Image: The CyberKnife S7 System (photo courtesy of Accuray)
A novel software solution enables clinicians to plan treatment plans for CyberKnife and conventional radiation therapy (RT) devices.
The RaySearch Laboratories AB (Stockholm, Sweden) RayStation is a unified treatment planning system (TPS) that supports Accuray (Sunnyvale, CA) CyberKnife M6 and S7 robotic stereotactic body RT (SBRT) systems, as well as other RT systems. It is compatible with all collimator types (fixed, Iris Variable Aperture, and InCise multileaf collimators). The software improves workflows, supports multiple RT prescriptions, multiple GPUs in photon Monte Carlo dose calculation, faster optimization, and more efficient memory allocation.
A new workflow feature defines tolerance tables, which are specifications of permitted deviations from various machine settings. The tolerance tables can be selected during planning and exported with the plan, which simplifies treatment delivery. Additional features include indication-specific motion tracking and adaptation with Accuray Synchrony technology; delivery of non-coplanar, isocentric, or non-isocentric treatment beams from potentially thousands of different angles; fast, accurate dose calculation that enables dose adjustment in real-time; and deformable registration and adaptive planning.
“The introduction of RayStation for the CyberKnife Systems will make it easier for providers with multiple radiotherapy systems to adopt and integrate Accuray technology seamlessly into their clinical operation,” said Suzanne Winter, chief commercial officer and senior vice president of R&D at Accuray. “Accuray CyberKnife, Radixact, and TomoTherapy systems interface with both RayStation and the Accuray Precision TPS, enabling our customers to optimize their experience and use of our technology over the long-term.”
“With the addition of CyberKnife planning support, RayStation becomes the first treatment planning system to support all major photon linacs,” said Björn Hårdemark, MSc, deputy CEO at RaySearch. “Both Radixact and CyberKnife are extremely versatile delivery platforms, and the ability to plan for these systems in parallel with conventional linacs makes it possible to easily assess which patients benefit the most from the capabilities of the Accuray systems.”
The CyberKnife System with the Synchrony motion synchronization technology uses artificial intelligence (AI) to adapt radiation delivery in real-time to patient and/or tumor movement throughout the course of treatment. The system's robotic design facilitates RT from potentially thousands of unique angles, maximizing radiation dose to the tumor and minimizing dose to surrounding healthy tissues.
Related Links:
RaySearch Laboratories AB
Accuray
The RaySearch Laboratories AB (Stockholm, Sweden) RayStation is a unified treatment planning system (TPS) that supports Accuray (Sunnyvale, CA) CyberKnife M6 and S7 robotic stereotactic body RT (SBRT) systems, as well as other RT systems. It is compatible with all collimator types (fixed, Iris Variable Aperture, and InCise multileaf collimators). The software improves workflows, supports multiple RT prescriptions, multiple GPUs in photon Monte Carlo dose calculation, faster optimization, and more efficient memory allocation.
A new workflow feature defines tolerance tables, which are specifications of permitted deviations from various machine settings. The tolerance tables can be selected during planning and exported with the plan, which simplifies treatment delivery. Additional features include indication-specific motion tracking and adaptation with Accuray Synchrony technology; delivery of non-coplanar, isocentric, or non-isocentric treatment beams from potentially thousands of different angles; fast, accurate dose calculation that enables dose adjustment in real-time; and deformable registration and adaptive planning.
“The introduction of RayStation for the CyberKnife Systems will make it easier for providers with multiple radiotherapy systems to adopt and integrate Accuray technology seamlessly into their clinical operation,” said Suzanne Winter, chief commercial officer and senior vice president of R&D at Accuray. “Accuray CyberKnife, Radixact, and TomoTherapy systems interface with both RayStation and the Accuray Precision TPS, enabling our customers to optimize their experience and use of our technology over the long-term.”
“With the addition of CyberKnife planning support, RayStation becomes the first treatment planning system to support all major photon linacs,” said Björn Hårdemark, MSc, deputy CEO at RaySearch. “Both Radixact and CyberKnife are extremely versatile delivery platforms, and the ability to plan for these systems in parallel with conventional linacs makes it possible to easily assess which patients benefit the most from the capabilities of the Accuray systems.”
The CyberKnife System with the Synchrony motion synchronization technology uses artificial intelligence (AI) to adapt radiation delivery in real-time to patient and/or tumor movement throughout the course of treatment. The system's robotic design facilitates RT from potentially thousands of unique angles, maximizing radiation dose to the tumor and minimizing dose to surrounding healthy tissues.
Related Links:
RaySearch Laboratories AB
Accuray
Latest Nuclear Medicine News
- New PET Tracer Detects DVT and Pulmonary Embolism in One Scan
- Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
- Portable PET System Enables Real-Time Bedside Guidance for Biopsies and Ablations
- AI Model Predicts Radiation Dose Before Prostate Cancer Therapy
- Vault-Free Radiosurgery Platform Expands Access to Cranial Tumor Care
- MR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
- New Imaging Tool Sheds Light on Tumor Fat Metabolism
- PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
- Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
- Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
Channels
Radiography
view channel
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read moreMRI
view channel
AI Reconstruction Tool Speeds Dynamic Breast MRI and Improves Cancer Detection
Breast cancer affects about 2.3 million people each year, creating sustained demand for precise imaging. Dynamic magnetic resonance imaging (MRI) is highly sensitive, yet slow acquisitions hinder real-time... Read more
International Study Assesses AI for Prostate Cancer MRI Interpretation
Prostate cancer is a leading cause of cancer morbidity in men, and accurate early diagnosis hinges on expert interpretation of prostate magnetic resonance imaging (MRI). Rapid adoption of MRI-first pathways... Read moreUltrasound
view channel
AI Ultrasound Platform Receives CE Mark for Prenatal Screening
Prenatal ultrasound is central to fetal anomaly screening, yet it remains one of the most technically demanding examinations in routine care. Because both image acquisition and interpretation are highly... Read more
Hybrid Imaging Platform Reveals How Sleep Supports Brain Waste Removal
The brain’s glymphatic system clears metabolic waste via cerebrospinal fluid and is thought to support neural health during sleep. Yet clinicians and researchers have struggled to observe its whole‑brain... Read moreGeneral/Advanced Imaging
view channel
Virtual Staining Technique Creates Histology Images from CT Data
Pulmonary hypertension, a disorder marked by pathological remodeling of the pulmonary vessels, often requires detailed histologic assessment. Yet routine pathology remains anchored in labor‑intensive,... Read more
CT-Derived Biomarker Predicts Outcomes in Gastric Cancer
Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more
AI Tool Enhances Response Assessment and Survival Prediction in Pleural Mesothelioma
Pleural mesothelioma, a cancer that grows as a thin, irregular layer along the lung wall, is difficult to measure on imaging. Clinicians rely on diameter-based Response Evaluation Criteria in Solid Tumors... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







